All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for youFind out more
Mantle cell lymphoma (MCL) is characterized by the chromosomal translocation t(11;14)(q13-3; q32-33), resulting in over-expression of the cell cycle protein, cyclin D1. MCL was only recognized as a separate entity in the 1990s. Novel targeted therapies have been approved for the treatment of MCL, however, many patients relapse and have a poor prognosis.
Save to your areas of interest